Bioinductive Patch for Full-Thickness Rotator Cuff Tears

February 24, 2026 updated by: Stephanie Muh, MD, Henry Ford Health System

Arthroscopic Rotator Cuff Repair Augmented With Bioinductive Implant for Full-Thickness Tears: A Randomized Controlled Study

The purpose of this randomized-controlled study is to compare outcomes of arthroscopic rotator cuff repair augmented with a Bioinductive Implant (study group) to standard arthroscopic rotator cuff repair (control group). The primary outcome of this study is rotator cuff repair integrity (absence of full- or partial-thickness defect) demonstrated on ultrasound at 1-year postoperatively. The investigators hypothesize that the study group will have higher rates of repair integrity demonstrated on ultrasound at 1-year postoperatively.

Study Overview

Detailed Description

A bioinductive patch is an implant that may foster tendon regrowth and healing following surgery. Patients will be randomized into one of two groups: control and investigational. All surgical patients will have failed non-surgical/conservative options for 6 weeks. Patients in the "control group" will receive the standard surgery (arthroscopic rotator cuff repair) . Patients in the "experimental group" will receive the same surgical treatment, with the addition of the bioinductive patch. This patch will be implanted during surgery. Then, using a combination of ultrasound studies and other measures, the investigators will assess how well the patch works compared to surgery alone.

Study Type

Interventional

Enrollment (Estimated)

78

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Stephanie J Muh, MD

Study Locations

    • Michigan
      • Detroit, Michigan, United States, 48202
        • Recruiting
        • Henry Ford Health
        • Contact:
        • Principal Investigator:
          • Stephanie J Muh, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Indicated and scheduled for arthroscopic rotator cuff repair.
  • Full-thickness medium (1-3 cm), large (3-5 cm), and massive (>5 cm) rotator cuff tears involving the supraspinatus and/or infraspinatus tendons demonstrated on magnetic resonance or ultrasound imaging.
  • Chronic, degenerative rotator cuff tears.
  • Ability to read and understand English.
  • Age ≥18 years
  • Patient failed ≥6 weeks of conservative treatment, which included structured, in-person physical therapy or documented home therapy

Exclusion Criteria:

  • Patient scheduled for open or mini-open rotator cuff repair
  • Prior surgery of affected shoulder (except diagnostic arthroscopy)
  • Partial-thickness rotator cuff tears
  • Small (<1 cm) rotator cuff tears
  • Rotator cuff tears involving the subscapularis tendon
  • Acute and traumatic rotator cuff tears
  • Active infection
  • Cancer
  • Autoimmune and rheumatologic disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
Surgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.
This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.
An ultrasound will be performed on each patient one year postoperatively.
Experimental: Study Group
Identical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.
This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.
An ultrasound will be performed on each patient one year postoperatively.
A bioinductive implant that is designed to promote healing of the torn rotator cuff tendon after surgery.
Other Names:
  • Bioinductive patch

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rotator cuff repair integrity
Time Frame: Preoperative to 1 year postoperative
absence of full- or partial-thickness defect as demonstrated on ultrasound at 1-year postoperatively.
Preoperative to 1 year postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications
Time Frame: Intraoperative to 2 years postoperative
Both intra- and postoperative complications will be collected.
Intraoperative to 2 years postoperative
PROMs scores for upper extremity function
Time Frame: Preoperative to 2 years postoperative
Patient-Reported Outcome Measures (PROMs) scores for upper extremity function. A T-score is given with a standard deviation based on the patients answers to the computerized adaptive test. The metrics have been designed to conform to a 0 - 100-point scale, with a score of 50 representing the mean of the population at large, 0 representing the minimum, and 100 representing the maximum function.
Preoperative to 2 years postoperative
PROMs scores for depression
Time Frame: Preoperative to 2 years postoperative
Patient-Reported Outcome Measures (PROMs) scores for depression. A T-score is given with a standard deviation based on the patients answers to the computerized adaptive test. The metrics have been designed to conform to a 10 - 90-point scale, with a score of 50 representing the mean of the population at large, 10 representing the minimum, and 90 representing the maximum function. A higher T-score represents higher increased depression (worse).
Preoperative to 2 years postoperative
PROMs scores for upper extremity pain interference
Time Frame: Preoperative to 2 years postoperative
Patient-Reported Outcome Measures (PROMs) scores for upper extremity pain and how it interferes with the patients daily life. A T-score is given with a standard deviation based on the patients answers to the computerized adaptive test. The metrics have been designed to conform to a 10 - 90-point scale, with a score of 50 representing the mean of the population at large, 10 representing the minimum, and 90 representing the maximum function. A higher T-score represents higher pain interference (worse).
Preoperative to 2 years postoperative
Shoulder Range of Motion
Time Frame: Preoperative to 2 years postoperative
Standard range of motion values collected by the surgeon during preoperative and followup visits
Preoperative to 2 years postoperative
Shoulder Strength
Time Frame: Preoperative to 2 years postoperative
Standard shoulder strength values collected by the surgeon during preoperative and followup visits. Medical Research Council Manual Muscle Testing scale will be used to measure the patient's strength on a 0 to 5 scale with 0 being the minimum and 5 being the maximum. Higher scores are better/normal.
Preoperative to 2 years postoperative
Reoperation
Time Frame: 2 years postoperative
Whether or not patients required another operation.
2 years postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Stephanie J Muh, MC, Henry Ford Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 16, 2022

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2029

Study Registration Dates

First Submitted

June 18, 2022

First Submitted That Met QC Criteria

June 27, 2022

First Posted (Actual)

June 30, 2022

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No IPD will be shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tears

Clinical Trials on arthroscopic rotator cuff repair

Subscribe